Drug combination induced apoptosis with increased cleaved-caspases-3, cleaved-PARP and DNA damage, reduced cell proliferation rate, and arrested CML cells in the S phase. Here, CASP3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.